CN109602705A - 一种重组人干扰素α2b喷雾剂 - Google Patents
一种重组人干扰素α2b喷雾剂 Download PDFInfo
- Publication number
- CN109602705A CN109602705A CN201811601446.4A CN201811601446A CN109602705A CN 109602705 A CN109602705 A CN 109602705A CN 201811601446 A CN201811601446 A CN 201811601446A CN 109602705 A CN109602705 A CN 109602705A
- Authority
- CN
- China
- Prior art keywords
- recombinant human
- interferon alpha
- human interferon
- spray
- auxiliary material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811601446.4A CN109602705A (zh) | 2018-12-26 | 2018-12-26 | 一种重组人干扰素α2b喷雾剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811601446.4A CN109602705A (zh) | 2018-12-26 | 2018-12-26 | 一种重组人干扰素α2b喷雾剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109602705A true CN109602705A (zh) | 2019-04-12 |
Family
ID=66011698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811601446.4A Pending CN109602705A (zh) | 2018-12-26 | 2018-12-26 | 一种重组人干扰素α2b喷雾剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109602705A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114259556A (zh) * | 2021-12-24 | 2022-04-01 | 科兴生物制药股份有限公司 | 人干扰素α2b喷雾剂及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1826132A (zh) * | 2003-07-22 | 2006-08-30 | 比奥泰康医疗有限责任公司 | 不加人血清白蛋白(hsa)的蛋白质药物制剂 |
CN1927388A (zh) * | 2004-09-10 | 2007-03-14 | 北京金迪克生物技术研究所 | 含有人干扰素的药物组合物 |
CN103143000A (zh) * | 2013-03-07 | 2013-06-12 | 安徽安科生物工程(集团)股份有限公司 | 一种重组人干扰素α2b制剂 |
CN104888196A (zh) * | 2015-06-25 | 2015-09-09 | 北京三元基因工程有限公司 | 一种稳定的干扰素α多剂量笔注射液 |
-
2018
- 2018-12-26 CN CN201811601446.4A patent/CN109602705A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1826132A (zh) * | 2003-07-22 | 2006-08-30 | 比奥泰康医疗有限责任公司 | 不加人血清白蛋白(hsa)的蛋白质药物制剂 |
CN1927388A (zh) * | 2004-09-10 | 2007-03-14 | 北京金迪克生物技术研究所 | 含有人干扰素的药物组合物 |
CN103143000A (zh) * | 2013-03-07 | 2013-06-12 | 安徽安科生物工程(集团)股份有限公司 | 一种重组人干扰素α2b制剂 |
CN104888196A (zh) * | 2015-06-25 | 2015-09-09 | 北京三元基因工程有限公司 | 一种稳定的干扰素α多剂量笔注射液 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114259556A (zh) * | 2021-12-24 | 2022-04-01 | 科兴生物制药股份有限公司 | 人干扰素α2b喷雾剂及其制备方法 |
CN114259556B (zh) * | 2021-12-24 | 2024-05-31 | 科兴生物制药股份有限公司 | 人干扰素α2b喷雾剂及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11919923B2 (en) | Antiviral application of nucleoside analog or combination formulation containing nucleoside analog | |
US11331331B2 (en) | N4-hydroxycytidine and derivatives and anti-viral uses related thereto | |
CN105001225B (zh) | 脂质合成的杂环调节剂 | |
ES2272732T3 (es) | Uso de derivados de nucleosidos antivirales para la preparacion de un medicamento para el tratamiento de infecciones de hepatitis c. | |
TW202385B (zh) | ||
CN111557939B (zh) | 法匹拉韦在制备用于治疗冠状病毒感染的药物中的应用 | |
JP2005515966A5 (zh) | ||
TW200426154A (en) | Antiviral nucleoside derivatives | |
EA016457B1 (ru) | Аналог тиофена для лечения вирусной инфекции гепатита с | |
JP2009521473A5 (zh) | ||
JP2009524585A (ja) | ウイルス感染を処置するためのジアリールウレア | |
CN101516192A (zh) | 5-氨基-3-(3’-脱氧-β-D-呋喃核糖基)-噻唑并[4,5-d]嘧啶-2,7-二酮的前药 | |
AU2016287580A2 (en) | Compositions and methods for the treatment of viral infection | |
CN110177551A (zh) | 脂质合成的杂环调节剂 | |
US9676763B2 (en) | Method of treating Ebola | |
CN109602705A (zh) | 一种重组人干扰素α2b喷雾剂 | |
JP2006527185A (ja) | 重症急性呼吸器症候群(sars)の治療または予防するためのグリチルリチンまたはその誘導体 | |
TW202200134A (zh) | 治療病毒感染、器官損傷及相關症狀之方法 | |
US20230144457A1 (en) | Methods for treating viral infections, organ injury, and related conditions | |
CN107126421A (zh) | 一种氢溴酸右美沙芬咀嚼片 | |
JPH02503557A (ja) | 治療用ヌクレオシド | |
JP2024518530A (ja) | ウイルス感染の予防及び治療のための二環式複素環化合物 | |
JPS5810577A (ja) | 2−セノイルメルカプトプロピオニルグリシンのエステル、その製造法およびそれを有効成分とする医薬組成物 | |
JPH02144A (ja) | デカプレニル置換アミノ酸誘導体および抗ウイルス剤 | |
CN108567785A (zh) | 毛壳素在制备治疗乙型病毒性肝炎的药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Ni Xiaoyan Inventor after: Wang Ronghai Inventor after: Lu Chen Inventor after: Wang Bing Inventor after: Song Lihua Inventor after: Zhou Lechun Inventor after: Chu Chengfeng Inventor after: Li Lianlian Inventor after: Rao Haijun Inventor before: Ni Xiaoyan Inventor before: Wang Ronghai Inventor before: Wang Bing Inventor before: Song Lihua Inventor before: Zhou Lechun Inventor before: Chu Chengfeng Inventor before: Li Lianlian Inventor before: Rao Haijun |
|
CB03 | Change of inventor or designer information | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190412 |
|
RJ01 | Rejection of invention patent application after publication |